Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Analyzing the Financial Impact of Biosimilar Use in the Oncology Care Model for the US Oncology Network

Puneeth Indurlal, MD, MS, The U.S. Oncology Network, McKesson, The Woodlands, TX, describes his study on the utilization and financial impact of biosimilar adoption in The Network during a performance period in the Oncology Care Model (OCM), a value-based care program from Medicare that rewards practices for decreasing the total cost of care. 

Findings from this study suggest that the increased utilization of biosimilars in The Network resulted in significant savings in OCM.

 

Advertisement

Advertisement

Advertisement